Lier Chemical Co., Ltd. Class A

Lier Chemical Co., Ltd. Class A

SSZSE:002258
14.13
CNY
+0.25
(+1.80%)
0.71EPS
21.90P/E
10.17BMarket Cap
Oct 27Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
3
3.12
2.15
2.72
4.2
5.49
5.67
6.77
8.83
13.56
9.81
9.13
11.25
11.91
Basic EPS, GAAP
0.22
0.22
0.2
0.29
0.55
0.79
0.42
0.83
1.46
2.43
0.75
0.27
0.6
0.58
Free Cash Flow per Basic Share
-0.4
-0.37
-0.21
-0.22
-0.29
-0.67
-0.2
0.61
0.7
0.52
-1.29
-1.09
0.27
- -
Dividend per Share
0.05
0.08
0.03
0.1
0.09
0.07
0.21
0.07
0.21
0.41
0.55
0.1
0.5
0.49
Book Value per Share
2.28
2.43
2.73
2.77
3.24
4.3
4.57
5.41
6.75
9.08
9.36
9.65
9.86
9.97
Tangible Book Value per Share
2.04
2.17
2.38
2.48
2.88
3.83
3.98
4.8
5.85
7.8
7.9
8.19
8.39
8.5
Basic Weighted Avg Shares
480
422
692
729
734
734
734
734
735
747
800
801
800
801
Sales/Revenue/Turnover
1,440
1,317
1,489
1,982
3,084
4,027
4,164
4,969
6,494
10,136
7,851
7,311
9,008
9,535
Operating Margin (%)
12.14
9.67
11.32
12.49
18.07
19.97
12.73
18.23
22.47
23.54
12.27
5.93
9.32
9.06
Depreciation Expense
59
82
109
144
184
260
346
389
495
566
629
820
988
- -
Net Income, GAAP
104
92
138
208
402
578
311
612
1,072
1,813
604
215
479
465
Effective Tax Rate (%)
14.48
16.19
13.94
13.49
14.22
12.41
12.15
13.28
12.45
14.44
12.53
12.87
16.31
15.61
Profit Margin (%)
7.23
7.01
9.3
10.51
13.04
14.35
7.47
12.32
16.51
17.88
7.69
2.95
5.32
4.87
Working Capital
383
357
261
536
533
857
671
985
2,036
1,559
1,550
1,623
1,300
809
LT Debt
50
170
209
149
366
1,014
1,112
964
1,553
571
2,010
2,172
2,337
2,107
Total Equity
1,332
1,405
1,551
2,296
2,787
3,686
4,034
4,709
5,825
8,383
8,748
9,011
9,254
9,359
Return on Invested Capital (%)
9.06
5.84
7.02
9.11
14.71
15.38
6.99
10.9
16.56
23.69
7.3
2.57
4.82
4.42
Return on Capital (%)
6.9
6.13
7.87
8.77
12.36
12.61
5.7
10.38
14.73
19.06
4.61
1.73
3.57
3.29
Return on Common Equity (%)
9.93
8.23
11.26
12.51
18.22
20.87
9.55
16.7
23.96
29.6
8.18
2.83
6.13
5.86

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,061
1,896
2,031
LT Borrowings
2,324
1,966
2,095
LT Finance Leases
14
12
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
800
800
800
Market Capitalization
10,446
11,526
10,174

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,482
6,001
6,277
Cash, Cash Equivalents & STI
1,175
945
1,113
Accounts Receivable, Net
2,116
2,567
2,414
Inventories
1,544
1,769
2,073
Total Current Liabilities
4,182
5,052
5,469
Payables & Accruals
- -
- -
- -
ST Debt
1,061
1,896
2,031
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.55%
15.53%
2.7%
Free Cash Flow
-81.57%
-103.14%
-124.53%
Net Income, GAAP
37.33%
27.1%
122.33%
Sales/Revenue/Turnover
22.26%
16.11%
23.21%
Total Cash Common Dividend
98.56%
131.7%
397.87%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,391
1,939
1,859
2,123
7,311
2025
2,086
2,421
- -
2,299
9,008
2026
2,312
2,503
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.06
0.05
0.1
0.27
2025
0.19
0.15
- -
0.12
0.6
2026
0.14
0.17
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.02
0.02
0.03
0.1
2025
0.03
0.22
- -
0.02
0.5
2026
0.02
0.22
- -
- -
- -

Company Description

CEO
Jiang Li
Full Time Employees
5,924
Sector
Process industries
Industry
Chemicals: agricultural
Address
Mianyang Eco Technical Dev Zone Chengdu SI China 621000
IPO Date
Jul 9, 2008
Business
Lier Chemical Co., Ltd. (002258.SZ) engages in the research, development, production, and sale of high-efficiency, low-toxicity, low-residue pesticides and chemical intermediates primarily for the agricultural sector in China and internationally. Founded in 1993 and headquartered in Mianyang Economic and Technological Development Zone, Sichuan Province, China, with additional facilities in Shanghai and Guang'an Lier Chemical Co., Ltd., a wholly-owned subsidiary, the company offers herbicides such as glyphosate, glufosinate-ammonium, diquat, flumioxazin, clodinafop-propargyl, clopyralid, picloram, fluroxypyr-meptyl, triclopyr, aminopyralid, pinoxaden, diuron, bensulfuron-methyl, linuron, pyrazosulfuron-ethyl, nicosulfuron, flufenacet, mefenacet, and quinclorac; fungicides including prothioconazole, azoxystrobin, epoxiconazole, iprodione, and difenoconazole; insecticides comprising chlorantraniliprole, chlorpyrifos, and pyriproxyfen; and intermediates such as 2-chloropyridine, 2,3-dichloropyridine, 2,5-dichloropyridine, 2,6-dichloropyridine, 2,3,4-trichloropyridine, 6-chloropyridine-2-carbonitrile, 3,6-difluoropyridine-2-carboxylic acid, and others. The company exports to over 30 countries and regions, including the United States, Brazil, Argentina, Australia, Canada, and India, with international sales accounting for 47% of revenue in 2024, and maintains long-term strategic cooperative relationships with global agrochemical leaders such as BASF SE and Corteva. Recent developments include plans to raise RMB 2.088 billion for a 10,000 t/a glufosinate technical production line and chloropyridine industry chain consolidation; investments in Guang'an Lier Chemical for 3,000 t/a pesticide intermediates, a 30,000-ton chloropyridine project with RMB 550 million total investment, and a RMB 980 million 10,000-ton glufosinate project; technical upgrading of chloropyridines production lines; and an earlier partnership with Nufarm for glufosinate supply, alongside expectations of nearly doubled net income in the first half of 2025 driven by volume and price increases in select products.